2,992 Shares in Humana Inc. (NYSE:HUM) Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB bought a new stake in shares of Humana Inc. (NYSE:HUM) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,992 shares of the insurance provider’s stock, valued at approximately $948,000.

Several other hedge funds have also recently added to or reduced their stakes in HUM. State Street Corp increased its position in shares of Humana by 1.0% during the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after buying an additional 53,272 shares during the period. FMR LLC lifted its position in Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after purchasing an additional 187,903 shares during the last quarter. Davis Selected Advisers lifted its holdings in shares of Humana by 16.1% in the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock valued at $863,640,000 after purchasing an additional 321,233 shares in the last quarter. Finally, Marshall Wace LLP boosted its position in shares of Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after buying an additional 774,085 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on HUM. Piper Sandler lowered shares of Humana from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. Truist Financial reduced their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target on the stock in a report on Tuesday, October 8th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and upped their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $304.15.

Humana Price Performance

HUM stock opened at $274.12 on Friday. The firm has a 50 day moving average of $274.13 and a 200-day moving average of $324.53. The firm has a market capitalization of $33.01 billion, a P/E ratio of 24.28, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $486.00. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, sell-side analysts predict that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.29%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.